Acesion Pharma ApS, of Copenhagen, appointed Anders Gaarsdal Holst chief medical officer and Birgitte Vestbjerg director clinical operations.
Century Therapeutics Inc., of Philadelphia, appointed Hiromitsu Nakauchi, Ellen Rothenberg, Barbara Kee, Cameron Turtle and Greg Delgoffe to its scientific advisory board. Marcela Maus will chair its clinical advisory board.
Immunomic Therapeutics Inc., of Rockville, Md., appointed Yang-gon Jin, Hyuk Joo Jee, Arlo McGinn, Bokhwan Chun and Alex S. Kim to its board.
Invectys SA, of Paris, appointed Dennis J. Purcell strategic adviser.
Jupiter Orphan Therapeutics Inc., of Jupiter, Fla., appointed Charbel Moussa to its scientific advisory board and named Mark Dant patient advocacy adviser.
Kezar Life Sciences Inc., of South San Francisco, appointed Noreen R. Henig chief medical officer.
Lifemax Laboratories Inc., of Redwood City, Calif., appointed Michael Huang chief medical officer.
Rallybio LLC, of Farmington, Conn., appointed Rachael Alford to lead the company’s chemistry, manufacturing and controls operations.
Recursion Pharmaceuticals Inc., of Salt Lake City, appointed R. Martin Chavez and Terry-Ann Burrell to its board.
Tessa Therapeutics Ltd., of Singapore, appointed Jeffrey H. Buchalter CEO and Göran A. Ando chair of its board.